Organization of the transforming growth factor- (TGF-) type I receptor (TRI) promoter predicts constitutive transcription, although its activity increases with differentiation status in cultured osteoblasts. Several sequences in the rat TRI promoter comprise cis-acting elements for CBFa (AML/PEBP2
✦ LIBER ✦
Repetitive exposure to TGF-β suppresses TGF-β type I receptor expression by differentiated osteoblasts
✍ Scribed by Kenneth K. Kim; Changhua Ji; Weizhong Chang; Rebecca G. Wells; Caren M. Gundberg; Thomas L. McCarthy; Michael Centrella
- Book ID
- 116507572
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 955 KB
- Volume
- 379
- Category
- Article
- ISSN
- 0378-1119
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
CBFa(AML/PEBP2)-related elements in the
✍
Changhua Ji; Sandra Casinghino; David J. Chang; Yun Chen; Amjad Javed; Yoshiaki
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 132 KB
👁 1 views
Increased TGFβ Type II Receptor Expressi
✍
Alessandra Turco; Susanna Scarpa; Anna Coppa; Gianluca Baccheschi; Camilla Palum
📂
Article
📅
2000
🏛
Elsevier Science
🌐
English
⚖ 427 KB
Modulation of Responses to TGF-β by 1,25
✍
T. Iimura; S. Oida; H. Ichijo; M. Goseki; Y. Maruoka; K. Takeda; S. Sasaki
📂
Article
📅
1994
🏛
Elsevier Science
🌐
English
⚖ 317 KB
Vascular types I and II transforming gro
✍
Michael R Ward; Alex Agrotis; Garry Jennings; Alex Bobik
📂
Article
📅
1998
🏛
Elsevier Science
🌐
English
⚖ 141 KB
Developmental Exposure to TCDD Alters En
✍
T. Nayyar; K. Bruner-Tran; G. Yeaman; E. Eisenberg; K. Osteen
📂
Article
📅
2005
🏛
Elsevier Science
🌐
English
⚖ 49 KB
TGF-β-1 up-regulates cyclin D1 expressio
✍
Marko Kornmann; Pam Tangvoranuntakul; Murray Korc
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
French
⚖ 174 KB
👁 1 views
Transforming growth factor-1 (TGF-1) inhibits cell growth in susceptible cells by interacting with a family of protein kinases that control cell cycle progression. In the present study, we investigated the effects of TGF-1 on cyclin D1 expression and activity in COLO-357 human pancreatic cancer c